Results 211 to 220 of about 6,793 (233)

A brief overview of imprint cytology in thoracic cytopathology. [PDF]

open access: yesCytojournal
Gardić N   +3 more
europepmc   +1 more source

Pulmonary Carcinoids: Diagnostic and Therapeutic Approach. [PDF]

open access: yesCancers (Basel)
Petrella F   +8 more
europepmc   +1 more source

Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens

International Journal of Clinical Oncology, 2012
It is often difficult to diagnose large cell neuroendocrine carcinomas (LCNEC) of the lung using small biopsy specimens. Some recent studies attempted to diagnose LCNEC using biopsy specimens; in 2011, the International Association for the Study of Lung Cancer pathological panels suggested possible LCNEC as a diagnosis for LCNEC by using biopsy ...
Takaaki, Tokito   +17 more
openaire   +2 more sources

Abstract 5452: Neuroendocrine negative RB1 WT SCLC and LCNEC

Cancer Research, 2020
Abstract Background: Based on genomics data generated in last few years about 15% of tumors diagnosed as large cell neuroendocrine carcinomas (LCNEC) are actually neuroendocrine negative. Interestingly, approximately similar percentage of small cell lung cancers (SCLC) are also neuroendocrine negative, historically known as SCLC variant ...
Dmitriy Sonkin   +2 more
openaire   +1 more source

Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum

General Thoracic and Cardiovascular Surgery, 2012
Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum is extremely rare. In this report, we present a case of a 53-year-old man with superior vena cava (SVC) syndrome who developed LCNEC in the middle mediastinum. His chief complaint was facial edema.
Ai, Maeda   +7 more
openaire   +2 more sources

Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)

Lung Cancer, 2020
Little is known regarding the ICPi efficacy in LCNEC. We explored the efficacy and safety of ICPi in LCNEC and assessed its impact on OS.Thirty-seven consecutive patients with advanced LCNEC were selected from the Davidoff Cancer Center database. These were divided into groups A1 (patients treated with ICPi, n-23) and A2 (patients not treated with ICPi,
Shira, Sherman   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy